EXPECTED IMPACT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION IN INVASIVE BACTERIAL INFECTION RATE IN THE PEDIATRIC EMERGENCY DEPARTMENT
ESPID Education. Gómez B. Jun 7, 2011; 7742
Dr. Borja Gómez
Dr. Borja Gómez

This content is available to ESPID members only


Click here for more information or if you are considering becoming an ESPID member.

Abstract
Discussion Forum (0)
Rate & Comment (0)
Expected impact of 13-valent pneumococcal conjugate vaccination in invasive bacterial infection rate in the pediatric emergency department

Gómez B *, Herrero M *, Gangoiti I*, Hernández JL **, Benito J *, Sánchez J *, Mintegi S *
* Pediatric Emergency Department. Cruces Hospital
** Microbiology Department. Cruces Hospital

Objective: To study the impact we can expect from the introduction of the 13-valent pneumococcal conjugate vaccine (PCV-13) in the spectrum of invasive bacterial infections (IBI) in the Pediatric Emergency Department (PED)

Methods: Retrospective study of children under 14 years diagnosed with an IBI (bacterial culture/protein chain reaction in blood or cerebrospinal fluid - CSF) in a PED of a tertiary hospital between January 2008 and December 2010.

Results: Among 180,202 episodes, an IBI was diagnosed in 88 patients (36, 40.9%, under 1 year).
The most frequent diagnoses were: sepsis with/without meningitis 28 (31.4%), bacteraemia 21 (23.6%), pneumonia 13 (14.6%), meningitis 9 (10.1%). The most commonly isolated bacteria were S. pneumoniae 33 (37.5%), N. meningitidis 21 (23.9%), E. Coli 9 (10.2%).
The bacterium was isolated from blood in 77 patients (27 pneumococcus, 18 meningococcus), from CSF in 3 (pneumococcus), and from both fluids in 8 (3 pneumococcus, 3 meningococcus, 2 Group B Streptococcus).
29 isolated pneumococcus were serotyped. The distribution of the serotypes related to the different PCV was: 5 were included in the PCV-7 (17.2% CI 95% 7.1-35.0), 15 in the PCV-10 (51.7%, 95% CI 34.4- 68.6) and 25 in the PCV-13 (86.2% CI 95% 68.8-95.1).
None of the patients died. Two patients with invasive pneumococcal infection had sequels.

Conclusions: In the era of 7-valent PCV, pneumococcus is the leading cause of IBI in PED. The introduction of 13-valent PCV may lead to a very significant decrease of IBI rate and meningococcus may become the leading cause of IBI.
Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings